Exploring the Prevalence and Characteristics Associated with Weight Gain and Metabolic Changes in PLWH who are Virologically Suppressed on Antiretroviral Therapy and Switch to Integrase Inhibitor Containing Regimens

Authors

Matty Zimmerman, Thomas Jefferson UniversityFollow
Joseph DeSimone Jr., MD, Thomas Jefferson UniversityFollow
Jason J. Schafer, PharmD, MPH, BCPS-AQ ID, BCIDP, AAHIVP, Thomas Jefferson UniversityFollow

Files

Description

Objectives

• To determine the prevalence, extent and characteristics of weight gain among virologically suppressed PLWH whose ART has been switched to an INSTI-containing regimen
• To examine the presence of metabolic changes in PLWH who have been switched to INSTI-containing ART

Publication Date

10-3-2019

Keywords

HIV, integrase inhibitor, weight gain

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Comments

Presented at ID Week

Recommended Citation

Zimmerman, Matty; DeSimone Jr., MD, Joseph; and Schafer, PharmD, MPH, BCPS-AQ ID, BCIDP, AAHIVP, Jason J., "Exploring the Prevalence and Characteristics Associated with Weight Gain and Metabolic Changes in PLWH who are Virologically Suppressed on Antiretroviral Therapy and Switch to Integrase Inhibitor Containing Regimens" (2019). College of Pharmacy Posters. 17.
https://jdc.jefferson.edu/pharmacyposters/17